<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
   xmlns:content="http://purl.org/rss/1.0/modules/content/"
   xmlns:dc="http://purl.org/dc/elements/1.1/"
   xmlns:atom="http://www.w3.org/2005/Atom"
   xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
   xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
   xmlns:company="http://purl.org/rss/1.0/modules/company"
>
	<channel>
		<title>Latest News - Market Wire News</title>
		<atom:link href="https://marketwirenews.com/rss/news-releases/?s=crdl" rel="self" type="application/rss+xml" />
		<link>https://marketwirenews.com</link>
		<description>Market Wire News RSS News Feed for Cardiol Therapeutics Inc. (NASDAQ: CRDL)</description>
		<lastBuildDate>Sun, 13 Sep 2026 11:42:48 -0400</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod> hourly </sy:updatePeriod>
		<sy:updateFrequency> 60 </sy:updateFrequency>

		<image>
			<url>https://marketwirenews.com/assets/img/icons/favicon-32x32.png</url>
			<title>Market Wire News</title>
			<link>https://marketwirenews.com</link>
			<width>32</width>
			<height>32</height>
		</image>
		<item>
            <title>Market Wire News Hottest Alerts Newsletter</title>
            <link>https://marketwirenews.com/newsletter/</link>
            <pubDate>Sun, 13 Sep 2026 11:42:48 -0400</pubDate>
            <dc:creator><![CDATA[Market Wire News]]></dc:creator>
            <category><![CDATA[Stock Picks]]></category>
            <category><![CDATA[Stock ALerts]]></category>
            <description><![CDATA[Subscribe to Market Wire News newsletter for instant real-time stock alerts, breaking financial news, trending stocks, and portfolio updates delivered to your email & mobile.]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/newsletter/?v=2864</guid>
          </item>
          <item>
            <title>Market Wire News Trending Stocks</title>
            <link>https://marketwirenews.com/trending-stocks/</link>
            <pubDate>Sun, 13 Sep 2026 11:42:48 -0400</pubDate>
            <dc:creator><![CDATA[Market Wire News]]></dc:creator>
            <category><![CDATA[Stock Picks]]></category>
            <category><![CDATA[Stock ALerts]]></category>
            <description><![CDATA[Track today's hottest trending stocks on NASDAQ, NYSE, OTCMKTS & Canadian markets. See massive % gainers, real-time movers, volumes, and linked breaking news updates.]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/trending-stocks/?v=2864</guid>
          </item>
          <item>
            <title>Market Wire News Investor Awarenewss</title>
            <link>https://marketwirenews.com/advertise/</link>
            <pubDate>Sun, 13 Sep 2026 11:42:48 -0400</pubDate>
            <dc:creator><![CDATA[Market Wire News]]></dc:creator>
            <category><![CDATA[Invesor Awareness]]></category>
            <category><![CDATA[Investor Releatios]]></category>
            <description><![CDATA[Stock Promoter, Investor Relations, Investor Awareness, Market Wire News, investor brand advertisement services, plans and pricing.]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/advertise/?v=2864</guid>
          </item>
		<item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews September 10, 2026 05:00:00 pm</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-files-us-150-million-preliminar-6606287584111135.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 10 Sep 2026 17:00:00 -0400</pubDate>
            <dc:creator><![CDATA[Canada Newswire]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission         Canada NewsWire        TORONTO ,  Sept. 10, 2026  /CNW/ -- Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Card...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-files-us-150-million-preliminar-6606287584111135.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews September 09, 2026 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-participate-in-a-fireside-ch-5623452778797542.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 09 Sep 2026 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[PR Newswire]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference         PR Newswire        TORONTO ,  Sept. 9, 2026  /PRNewswire/ -- Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (" Cardiol " or the " Company "), a late-stage life scie...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-participate-in-a-fireside-ch-5623452778797542.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews August 05, 2026 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-participate-in-fireside-chat-6811107910038380.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 05 Aug 2026 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[Canada Newswire]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference         Canada NewsWire        TORONTO ,  Aug. 5, 2026  /CNW/ -- Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (" Cardiol " or the " Company "), a late-stage life sciences company adva...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-participate-in-fireside-chat-6811107910038380.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews July 14, 2026 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-phase-ii-recurrent-pericarditis-8751272266677626.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 14 Jul 2026 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[PR Newswire]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Cardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association         PR Newswire        &#x2022; Peer-reviewed&#xA0;JAHA publication strengthens the foundation for Cardiol's pivotal Phase III MAVERIC trial as enrollment nears completion.   ...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-phase-ii-recurrent-pericarditis-8751272266677626.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews July 09, 2026 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-participate-in-fireside-chat-8648353327091671.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 09 Jul 2026 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[PR Newswire]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Cardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle &amp; Vision Summit         Cardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle &amp; Vision Summit   PR Newswire        TORONTO ,  July 9, 2026  /PRNewswire/ - Cardiol Th...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-participate-in-fireside-chat-8648353327091671.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews June 25, 2026 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-reports-results-of-2026-annual--4724176029393650.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 25 Jun 2026 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[PR Newswire]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders         PR Newswire        TORONTO ,  June 25, 2026  /PRNewswire/ -&#xA0;Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflamm...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-reports-results-of-2026-annual--4724176029393650.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews June 23, 2026 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-webcast-virtual-annual-gener-5931033974514739.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 23 Jun 2026 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[Canada Newswire]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT         Canada NewsWire        TORONTO ,  June 23, 2026  /CNW/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advan...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-webcast-virtual-annual-gener-5931033974514739.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews May 14, 2026 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-participate-in-fireside-chat-5235192447348985.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 14 May 2026 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[PR Newswire]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ         PR Newswire        TORONTO ,  May 14, 2026  /PRNewswire/ -&#xA0;Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (" Cardiol " or the " Company "), a late-sta...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-participate-in-fireside-chat-5235192447348985.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews May 07, 2026 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-phase-ii-maveric-results-accept-6575142401542784.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 07 May 2026 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[Canada Newswire]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association         Canada NewsWire         Results demonstrate CardiolRx&#x2122; may represent a paradigm shift in the treatment of patients with recurrent pericarditis and further valida...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-phase-ii-maveric-results-accept-6575142401542784.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews April 28, 2026 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-expands-u-s-maveric-phase-iii-t-7404980237675459.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 28 Apr 2026 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[Canada Newswire]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal Program         Canada NewsWire         Leading enrolling centers include Cleveland Clinic, three major campuses of the Mayo Clinic, Northwestern University, Massachusetts General Hospital...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-expands-u-s-maveric-phase-iii-t-7404980237675459.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews April 14, 2026 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-highlight-maveric-phase-iii--8909756354417556.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 14 Apr 2026 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[TMX Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Toronto, Ontario--(Newsfile Corp. - April 14, 2026) - Cardiol Therapeutics Inc.  (NASDAQ: CRDL) (TSX: CRDL)  (" Cardiol " or the " Company "), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, is pleased to ...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-highlight-maveric-phase-iii--8909756354417556.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews April 01, 2026 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-announces-year-end-2025-update--4812762336614333.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 01 Apr 2026 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[TMX Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Initiated pivotal Phase III MAVERIC trial of CardiolRx&#x2122; in recurrent pericarditis and surpassed 50% patient enrollment, with full enrollment expected in Q2 2026.      Reported positive Phase II ARCHER data showing CardiolRx&#x2122; significantly reduced left ventricular mass in patients wi...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-announces-year-end-2025-update--4812762336614333.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews February 25, 2026 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-present-at-td-cowen-46th-ann-5936579025095012.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 25 Feb 2026 07:27:00 -0500</pubDate>
            <dc:creator><![CDATA[TMX Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Toronto, Ontario--(Newsfile Corp. - February 25, 2026) - Cardiol Therapeutics Inc.  (NASDAQ: CRDL) (TSX: CRDL)  (" Cardiol " or the " Company "), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, is pleased ...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-present-at-td-cowen-46th-ann-5936579025095012.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews February 10, 2026 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-archer-phase-ii-study-results-p-6079352668353270.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 10 Feb 2026 07:27:00 -0500</pubDate>
            <dc:creator><![CDATA[TMX Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Toronto, Ontario--(Newsfile Corp. - February 10, 2026) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL) (TSX: CRDL ) (" Cardiol " or the " Company "), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today annou...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-archer-phase-ii-study-results-p-6079352668353270.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews January 23, 2026 09:16:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-announces-closing-of-bought-dea-7360508109175793.html?utm_source=rss-news-releases</link>
            <pubDate>Fri, 23 Jan 2026 09:16:00 -0500</pubDate>
            <dc:creator><![CDATA[TMX Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Toronto, Ontario--(Newsfile Corp. - January 23, 2026) - Cardiol Therapeutics Inc.  (NASDAQ: CRDL) (TSX: CRDL)  (" Cardiol " or the " Company "), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announ...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-announces-closing-of-bought-dea-7360508109175793.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews January 16, 2026 08:46:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-announces-bought-deal-financing-7857647346395447.html?utm_source=rss-news-releases</link>
            <pubDate>Fri, 16 Jan 2026 08:46:00 -0500</pubDate>
            <dc:creator><![CDATA[TMX Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - Cardiol Therapeutics Inc.  (NASDAQ: CRDL) (TSX: CRDL)  (" Cardiol " or the " Company "), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announ...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-announces-bought-deal-financing-7857647346395447.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews January 16, 2026 08:42:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-inc-announces-bought-deal-finan-6434476049481088.html?utm_source=rss-news-releases</link>
            <pubDate>Fri, 16 Jan 2026 08:42:00 -0500</pubDate>
            <dc:creator><![CDATA[TMX Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - Cardiol Therapeutics Inc.  (NASDAQ: CRDL) (TSX: CRDL)  (" Cardiol " or the " Company "), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announ...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-inc-announces-bought-deal-finan-6434476049481088.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews January 13, 2026 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-achieves-key-50-patient-enrollm-5442655087000693.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 13 Jan 2026 07:27:00 -0500</pubDate>
            <dc:creator><![CDATA[Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Clinical trial infrastructure fully operational in the U.S. with more than 15 leading cardiovascular centers actively enrolling patients.      Activation of additional top-tier clinical sites in Europe and Canada underway, further accelerating enrollment momentum.      Full enrollment expected in...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-achieves-key-50-patient-enrollm-5442655087000693.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews December 01, 2025 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/new-data-from-the-phase-ii-archer-trial-demonstrate--8581441551413795.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 01 Dec 2025 07:27:00 -0500</pubDate>
            <dc:creator><![CDATA[Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Phase II ARCHER trial showed a significant reduction in left ventricular (LV) mass (p=0.0117) and improvements in multiple key cardiac MRI (CMR) measures of structural heart recovery in patients with acute myocarditis.      Results provide clinical evidence that CardiolRx&#x2122; reduces inflamma...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/new-data-from-the-phase-ii-archer-trial-demonstrate--8581441551413795.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews November 13, 2025 07:45:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-receives-u-s-patent-allowance-b-7499485615704382.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 13 Nov 2025 07:45:00 -0500</pubDate>
            <dc:creator><![CDATA[Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Once issued, this new U.S. patent covers the use of CardiolRx&#x2122; and CRD-38 for a broad range of cardiac disorders, including atherosclerosis and heart failure, significantly expanding intellectual property protection in the world's largest pharmaceutical market.      This allowance fortifie...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-receives-u-s-patent-allowance-b-7499485615704382.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews November 05, 2025 07:45:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-phase-ii-archer-trial-results-t-5354647819531759.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 05 Nov 2025 07:45:00 -0500</pubDate>
            <dc:creator><![CDATA[Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[The ESC M&amp;PD meeting brings together the world's experts working to improve the treatment of myocarditis and pericarditis.      Presentation to provide comprehensive findings from the ARCHER trial following the reporting of topline results demonstrating a notable improvement in extracellular ...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-phase-ii-archer-trial-results-t-5354647819531759.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews October 21, 2025 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-completes-us-11-4-million-finan-8078500851705957.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 21 Oct 2025 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx&#x2122; in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA.      New data from the ARCHER trial, highlighting the magnitude of reduction in left ventricular (LV) mass and th...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-completes-us-11-4-million-finan-8078500851705957.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews October 17, 2025 04:34:00 pm</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-secures-us-11-million-financing-7969423887523326.html?utm_source=rss-news-releases</link>
            <pubDate>Fri, 17 Oct 2025 16:34:00 -0400</pubDate>
            <dc:creator><![CDATA[Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx&#x2122; in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA.      New data from the ARCHER trial, highlighting the magnitude of reduction in left ventricular (LV) mass and th...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-secures-us-11-million-financing-7969423887523326.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews May 29, 2025 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-reports-results-of-2025-annual--4544200996442606.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 29 May 2025 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) (" Cardiol " or the " Company "), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, announces t...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-reports-results-of-2025-annual--4544200996442606.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews May 27, 2025 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-webcast-virtual-annual-gener-4669630529134781.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 27 May 2025 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Toronto, Ontario--(Newsfile Corp. - May 27, 2025) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) (" Cardiol " or the " Company "), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, announces t...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-webcast-virtual-annual-gener-4669630529134781.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews April 29, 2025 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-nominates-dr-timothy-garnett-to-7860684571095350.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 29 Apr 2025 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Former Chief Medical Officer of Eli Lilly brings more than thirty years of pharmaceutical industry experience  Toronto, Ontario--(Newsfile Corp. - April 29, 2025) - Cardiol Therapeutics Inc.  (NASDAQ: CRDL) (TSX: CRDL)  (" Cardiol " or the " Company "), a clinical-stage life sciences company focu...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-nominates-dr-timothy-garnett-to-7860684571095350.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews April 16, 2025 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-enrolls-first-patient-in-pivota-7366741886721543.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 16 Apr 2025 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Designed to assess the impact of CardiolRx&#x2122; on preventing episodes of recurrent pericarditis, the first patient has been randomized by Northwestern University in Chicago.      Based on a successful end-of-Phase II meeting with the US FDA and subject to MAVERIC outcomes, Cardiol believes th...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-enrolls-first-patient-in-pivota-7366741886721543.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews April 01, 2025 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-announces-year-end-2024-update--7960836243022740.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 01 Apr 2025 07:27:00 -0400</pubDate>
            <dc:creator><![CDATA[Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Reported positive data from the Phase II MAvERIC-Pilot study investigating the impact of CardiolRx&#x2122; administered to patients with symptomatic recurrent pericarditis; results support advancing to the Phase III MAVERIC trial  Completed patient enrollment in the Phase II ARCHER trial evaluati...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-announces-year-end-2024-update--7960836243022740.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews March 03, 2025 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-present-at-td-cowen-45th-ann-8648150633644935.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 03 Mar 2025 07:27:00 -0500</pubDate>
            <dc:creator><![CDATA[Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Toronto, Ontario--(Newsfile Corp. - March 3, 2025) - Cardiol Therapeutics Inc.  (NASDAQ: CRDL) (TSX: CRDL)  (" Cardiol " or the " Company "), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased t...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-present-at-td-cowen-45th-ann-8648150633644935.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews February 20, 2025 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-announces-publication-of-resear-7465285368165276.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 20 Feb 2025 07:27:00 -0500</pubDate>
            <dc:creator><![CDATA[Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Data demonstrates improvement in cardiac function and reductions in cardiac hypertrophy, remodeling, inflammation, and cell death - key underlying mechanisms in heart failure  Toronto, Ontario--(Newsfile Corp. - February 20, 2025) - Cardiol Therapeutics Inc.  (NASDAQ: CRDL) (TSX: CRDL)  (" Cardio...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-announces-publication-of-resear-7465285368165276.html?s=crdl?v=<?php echo 2864;?></guid>
            </item><item>
            <title>$CRDL Cardiol Therapeutics Inc #MWN #BreakingNews February 04, 2025 07:27:00 am</title>
            <link>https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-present-at-oppenheimer-35th--7204730377302311.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 04 Feb 2025 07:27:00 -0500</pubDate>
            <dc:creator><![CDATA[Newsfile]]></dc:creator>
            <category><![CDATA[CRDL]]></category>
            <category><![CDATA[Cardiol Therapeutics Inc.]]></category>
            <description><![CDATA[Toronto, Ontario--(Newsfile Corp. - February 4, 2025) - Cardiol Therapeutics Inc.  (NASDAQ: CRDL) (TSX: CRDL)  (" Cardiol " or the " Company "), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatme...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/crdl/news/cardiol-therapeutics-to-present-at-oppenheimer-35th--7204730377302311.html?s=crdl?v=<?php echo 2864;?></guid>
            </item>
	</channel>
</rss>